158 related articles for article (PubMed ID: 3803413)
1. Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schirger A; Fisher LD; Shub C; Collins JB; Spiekerman RE
Eur J Clin Pharmacol; 1986; 31(2):133-41. PubMed ID: 3803413
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparator trials with pinacidil, a potassium channel opener.
Callaghan JT; Goldberg MR; Brunelle R
Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139
[TBL] [Abstract][Full Text] [Related]
4. Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.
Carlsen JE; Jensen HA; Rehling M; Lund JO; Trap-Jensen J
Drugs; 1988; 36 Suppl 7():55-63. PubMed ID: 3076136
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
Byyny RL; Nies AS; LoVerde ME; Mitchell WD
Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
7. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
Goldberg MR; Offen WW
Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin.
Goldberg MR; Sushak CS; Rockhold FW; Thompson WL
Clin Pharmacol Ther; 1988 Jul; 44(1):78-92. PubMed ID: 3292105
[TBL] [Abstract][Full Text] [Related]
9. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
[TBL] [Abstract][Full Text] [Related]
10. Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group.
Br J Clin Pharmacol; 1986 Jun; 21(6):621-6. PubMed ID: 2874821
[TBL] [Abstract][Full Text] [Related]
11. The antihypertensive effect of pinacidil versus prazosin in mild to moderate hypertensive patients seen in general practice.
Sterndorff B; Johansen P
Acta Med Scand; 1988; 224(4):329-36. PubMed ID: 3188983
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.
Goldberg MR
J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S41-7. PubMed ID: 2466178
[TBL] [Abstract][Full Text] [Related]
13. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Friedel HA; Brogden RN
Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evaluation of pinacidil in hypertension.
Ramsay LE; Freestone S
Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
[TBL] [Abstract][Full Text] [Related]
15. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
Fletcher AE; Battersby C; Adnitt P; Underwood N; Jurgensen HJ; Bulpitt CJ
J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618
[TBL] [Abstract][Full Text] [Related]
16. Effects of pinacidil on the heart: serial electrocardiographic and echocardiographic observations.
Shub C; Zachariah PK; Ilstrup DM; Tajik AJ
Can J Cardiol; 1987; 3(5):223-9. PubMed ID: 3300903
[TBL] [Abstract][Full Text] [Related]
17. The natural history of medication compliance in a drug trial: limitations of pill counts.
Rudd P; Byyny RL; Zachary V; LoVerde ME; Titus C; Mitchell WD; Marshall G
Clin Pharmacol Ther; 1989 Aug; 46(2):169-76. PubMed ID: 2667837
[TBL] [Abstract][Full Text] [Related]
18. Pinacidil monotherapy for hypertension.
Ward JW
Br J Clin Pharmacol; 1984 Aug; 18(2):223-5. PubMed ID: 6487460
[TBL] [Abstract][Full Text] [Related]
19. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
Muiesan G; Fariello R; Muiesan ML; Christensen OE
Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]